期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Carry Out Open Standard & Promote Independent Creation Seminar of "Open Standard, Intellectual Property Rights and Innovation"
1
作者 Ni Guangnan 《China Standardization》 2007年第1期18-22,共5页
关键词 Promote Independent Creation Seminar of intellectual Property Rights and innovation Carry Out Open Standard OSS Office OPEN Open Standard Linux
下载PDF
The Intellectual Property Court Edges Its Way Forward
2
作者 JIN SHANMING 《China Today》 2015年第7期66-67,共2页
INTELLECTUAL property is highly valued the world over,including in China.The Decision on Some Major Issues Concerning Comprehensively Deepening Reform,released in November 2013 at the Third Plenary Session of the 18th... INTELLECTUAL property is highly valued the world over,including in China.The Decision on Some Major Issues Concerning Comprehensively Deepening Reform,released in November 2013 at the Third Plenary Session of the 18th Communist Party of China(CPC)Central Committee,said explicitly:"We will strengthen the application and protection of intellectual property rights(IPR),improve the technological innovation incentive mechanism,and explore ways to set up IPR courts." On August 31, 2014, the National People's Congress, China's top legislature, voted to establish IPR courts in Beijing, Shanghai, and Guangzhou. They soon came into being, constituting a milestone in China's IPR protection. 展开更多
关键词 technological intellectual explicitly Forward court incentive Communist Major strengthen innovative
下载PDF
Yu Dechao:Developer of Chinese Biopharmaceuticals
3
作者 GONG HAN 《China Today》 2016年第10期31-33,共3页
AS a distinguished expert on China’s Thousand Talents Program,Yu Dechao is a heavyweight in the country’s biological pharmacy.As a major founder of Oncorine,the world’s first patented anti-tumor virus therapy drug,... AS a distinguished expert on China’s Thousand Talents Program,Yu Dechao is a heavyweight in the country’s biological pharmacy.As a major founder of Oncorine,the world’s first patented anti-tumor virus therapy drug,he also invented Conbercept,China’s first monoclonal antibody drug whose global intellectual property rights it owns. 展开更多
关键词 Developer intellectual distinguished pharmacy founder monoclonal innovative pharmaceutical devote medicines
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部